Evaluation of the effect of acetylene drug in comparison with oral administration of pantoprazole in controlling symptoms of gastro-esophageal reflux.
- Conditions
- Gastro-esophageal reflux.Gastro-esophageal reflux disease
- Registration Number
- IRCT20180422039378N1
- Lead Sponsor
- Bagheiat-allah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Completion of informed consent form
Diagnosis of reflux disease is confirmed by clinical and paraclinical findings.
The patient's condition is not life-threatening.
Do not participate in another clinical trial at the same time.
Do not interact with medication before intervention. Like beta blocker inhibitors and herbal medicines or drugs that are harmful for treatment of reflux, such as theophylline, and others.
Age over 18 years
No smoking in the past
Not pregnancy
Failure to enter the plan for patients with psychiatric and veterinary injuries due to pulmonary symptoms
The occurrence of severe drug-related symptoms and severe hypersensitivity to drugs that can not be controlled.
Signs and symptoms of the patient have worsened during the study.
Those patients who have not consumed their medication for more than a week.
History of chemical gas and severe pulmonary disease.
Pregnant or intending to have a pregnancy
Presence and observation of drug interactions
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptoms of Gastro-esophageal reflux Disease. Timepoint: Before starting treatment, as well as at 3 and 6 weeks after starting treatment. Method of measurement: Interview with patients using reflux symptom index questionnaire.
- Secondary Outcome Measures
Name Time Method